HOME Top Market Reports Prosthetic Heart Valve/ Artificial Heart Valve Market by Type (Transcatheter Heart Valve, Tissue Heart Valve, and Mechanical Heart Valve), and Region (North America, Europe, Asia-Pacific, and RoW) - Global Forecast to 2022

Prosthetic Heart Valve/ Artificial Heart Valve Market by Type (Transcatheter Heart Valve, Tissue Heart Valve, and Mechanical Heart Valve), and Region (North America, Europe, Asia-Pacific, and RoW) - Global Forecast to 2022

By: marketsandmarkets.com
Publishing Date: June 2017
Report Code: MD 4094

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The prosthetic heart valve market is projected to reach USD 8.86 Billion by 2022 from USD 4.84 Billion in 2017, at a CAGR of 12.9%. Market growth can be attributed to the rising geriatric population and the subsequent increase in the prevalence of HVD, regulatory approvals for new and advanced prosthetic heart valves, increasing government funding for heart valve research, rising awareness about HVD, and favorable reimbursement scenario for prosthetic heart valves.

Years considered for this report

2016 – Base Year
2017 – Estimated Year
2022 – Projected Year

The objectives for this study are as follows:

  • To define, describe, and forecast the prosthetic heart valve market on the basis of type of valve and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
  • To strategically analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW)
  • To profile the key players and comprehensively analyze their market shares and core competencies in terms of market development and growth strategies
  • To track and analyze competitive developments such as marketing and promotional activities, approvals, product launches, acquisitions, agreements, collaborations, expansions, certifications, and reimbursement approvals in the prosthetic heart valves market

Research Methodology

Top-down and bottom-up approaches were used to estimate and validate the size of the prosthetic heart valve market and to estimate the size of various other dependent submarkets. The overall market size was used in the top-down approach to estimate the sizes of other individual markets (mentioned in the market segmentation by type of valve and region) through percentage splits from secondary and primary research. For the calculation of each type of specific market segment, the most appropriate immediate parent market size was used for implementing the top-down approach. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained. The bottom-up approach was employed to arrive at the overall size of the market from the sales of prosthetic heart valves in the respective four regions. Various secondary sources such as directories, industry journals, and databases have been used to identify and collect information useful for this extensive commercial study of the prosthetic heart valve market. Primary sources such as experts from related industries and suppliers have been interviewed to obtain and verify critical information as well as to assess prospects of the prosthetic heart valve market. The breakdown of primaries is shown in the figure below:

Heart Valve/ Artificial Heart Valve Market

To know about the assumptions considered for the study, download the pdf brochure

The key players in the artificial heart valve market are Medtronic plc (Ireland), Edwards Lifesciences Corporation (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (an Abbott Laboratories Company) (U.S.), LivaNova PLC (U.K.), Symetis SA (Switzerland), Jenavalve Technology, Inc. (Germany), CryoLife, Inc. (U.S.), TTK Healthcare Limited (India), Colibri Heart Valve, LLC (U.S.), Lepu Medical Technology Co., Ltd. (China), and Braile Biomιdica (Brazil).

Target Audience for this Report:

  • Prosthetic Heart Valve Manufacturing Companies
  • Suppliers and Distributors of Prosthetic Heart Valves
  • Healthcare Service Providers
  • Teaching Hospitals and Academic Medical Centers (AMCs)
  • Health Insurance Players
  • Research and Consulting Firms
  • Medical Research Institutes
  • Audiology Centers
  • Healthcare Institutions/Providers (Hospitals, Medical Institutes, and Governing Bodies)
  • Venture Capitalists
  • Community Centers
  • Regulatory Authorities

Value Addition for the Buyer:

This report aims to provide insights into the global prosthetic heart valve market. It provides valuable information on the types of valves and regions in the artificial heart valves market. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

The above-mentioned information would benefit the buyer by helping them understand the market dynamics. In addition, the forecasts provided in the report will enable firms to understand the trends in this market and better position themselves to capitalize the growth opportunities.

Scope of the Report:

This research report categorizes the global prosthetic heart valve market into the following segments:

Prosthetic Heart Valve Market, by Type of Valve

  • Transcatheter Heart Valves
  • Tissue Heart Valves
  • Mechanical Heart Valves

Prosthetic Heart Valve Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Rest of Europe (RoE)
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific (RoAPAC)
  • Rest of the World (RoW)

Available Customizations:

  • Portfolio Assessment: Product Matrix, which gives a detailed comparison of the product portfolios of the top three companies in the market
  • Market Size Analysis: Prosthetic Heart Valves Market, by Valve Replacement (Aortic Heart Valves, Mitral Heart Valves, Pulmonary Heart Valves, and Tricuspid Heart Valves)
  • Company Information: Detailed company profiles of up to 3 market players

Table of Contents

1 Artificial Heart Valve Market: Introduction (Page No. - 15)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Artificial Heart Valve Market: Research Methodology (Page No. - 19)
    2.1 Research Methodology Steps
    2.2 Secondary and Primary Research Methodology
           2.2.1 Secondary Research
           2.2.2 Primary Research
                    2.2.2.1 Key Industry Insights
                    2.2.2.2 Key Data From Primary Sources
                    2.2.2.3 Key Insights From Primary Sources
    2.3 Market Size Estimation Methodology
    2.4 Research Design
    2.5 Market Data Validation and Triangulation
    2.6 Assumptions for the Study

3 Artificial Heart Valve Market: Executive Summary (Page No. - 32)

4 Artificial Heart Valve Market: Premium Insights (Page No. - 35)
    4.1 Introduction
    4.2 Global Prosthetic Heart Valves Market, By Type of Valve, 2017 vs 2022
    4.3 Geographical Snapshot of Global Prosthetic Heart Valves Market

5 Artificial Heart Valve Market: Overview (Page No. - 38)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Rising Geriatric Population and Subsequent Growth in Prevalence of Heart Valve Disease
                    5.2.1.2 Regulatory Approvals for New and Advanced Prosthetic Heart Valves
                               5.2.1.2.1 Product Approvals for Medtronic PLC:
                               5.2.1.2.2 Product Approvals for Edward Lifesciences Corporation:
                               5.2.1.2.3 Product Approvals for Boston Scientific Corporation:
                               5.2.1.2.4 Product Approvals for Livanova PLC:
                               5.2.1.2.5 Product Approvals for St. Jude Medical, Inc.:
                               5.2.1.2.6 Product Approvals for Other Companies:
                    5.2.1.3 Increasing Government Funding for Heart Valve Research
                    5.2.1.4 Rising Awareness About Heart Valve Diseases
                    5.2.1.5 Favorable Reimbursement Scenario for Prosthetic Heart Valves
           5.2.2 Restraints
                    5.2.2.1 High Cost of Transcatheter Aortic Valve Replacement (TAVR) Procedures
                    5.2.2.2 Availability of Alternative Methods for Treating Heart Valve Diseases (HVD)
           5.2.3 Opportunities
                    5.2.3.1 Expanding Indication of TAVR From Only High-Risk to Intermediate- Or Low-Risk Patients
                    5.2.3.2 Strong Product Pipeline
                    5.2.3.3 Increasing Investments By Key Players in Startup Companies
                    5.2.3.4 Growth Potential Offered By Emerging Countries
           5.2.4 Challenge
                    5.2.4.1 Emergence of Tissue-Engineered Heart Valves (TEHV)

6 Global Prosthetic Heart Valve Market, By Type of Valve (Page No. - 50)
    6.1 Introduction
    6.2 Transcatheter Heart Valves
    6.3 Tissue Heart Valves
    6.4 Mechanical Heart Valves

7 Global Prosthetic Heart Valve Market, By Region (Page No. - 65)
    7.1 Introduction
    7.2 North America
           7.2.1 U.S.
                    7.2.1.1 Rapid Growth in the Aging Population and Prevalence of Valvular Heart Diseases
                    7.2.1.2 Rising Preference for Transcatheter Aortic Valve Replacement (TAVR)
                    7.2.1.3 Favorable Reimbursement Scenario for Prosthetic Heart Valves
                    7.2.1.4 Initiatives to Increase Awareness of Valvular Heart Diseases (VHD)
                    7.2.1.5 Stringent Regulations for New Prosthetic Heart Valve Approval
           7.2.2 Canada
                    7.2.2.1 Favorable Reimbursement and Funding
                    7.2.2.2 Rising Approvals for Heart Valves
    7.3 Europe
           7.3.1 Increasing Aging Population and Valvular Heart Diseases (VHD) Prevalence
           7.3.2 Growth in the Number of Research Activities
           7.3.3 Germany
                    7.3.3.1 Favorable Reimbursement Policies
           7.3.4 France
                    7.3.4.1 Valve for Life (VFL) Initiative
           7.3.5 U.K.
                    7.3.5.1 Establishment of Specialty Valve Clinics
           7.3.6 Rest of Europe (RoE)
                    7.3.6.1 Rising Initiatives and Awareness Programs in Poland and Portugal
    7.4 Asia-Pacific
           7.4.1 Japan
                    7.4.1.1 Rising Aging Population
                    7.4.1.2 Favorable Reimbursement Scenario
                    7.4.1.3 Dilution of Regulatory Stringency
           7.4.2 China
                    7.4.2.1 Rising Aging Population and Prevalence of Valvular Heart Diseases in China
                    7.4.2.2 Unfavorable Reimbursements
           7.4.3 India
                    7.4.3.1 High Patient Pool for Target Diseases
                    7.4.3.2 State Government Funded Insurance Schemes
           7.4.4 Rest of Asia-Pacific (RoAPAC)
                    7.4.4.1 Growing Medical Tourism in Asian Countries
    7.5 Rest of the World
           7.5.1 Rise in Aging Population
           7.5.2 High Prevalence of Heart Valve Disease in Brazil
           7.5.3 Favorable Medical Tourism Destination

8 Artificial Heart Valve Market: Competitive Landscape (Page No. - 92)
    8.1 Market Share Analysis (2016)
           8.1.1 Introduction
           8.1.2 Global Transcatheter Heart Valves Market Share, By Key Player, 2016
           8.1.3 Global Tissue Heart Valves Market Share, By Key Player, 2016
           8.1.4 Global Mechanical Heart Valves Market Share, By Key Player, 2016
           8.1.5 Edwards Lifesciences Corporation
           8.1.6 Medtronic PLC
           8.1.7 St. Jude Medical, Inc.
    8.2 Vendor Dive Overview
           8.2.1 Vanguards
           8.2.2 Innovator
           8.2.3 Dynamic
           8.2.4 Emerging
    8.3 Competitive Benchmarking
           8.3.1 Analysis of Product Portfolio of Major Players in the Prosthetic Heart Valve Market (18 Players)
           8.3.2 Business Strategies Adopted By Major Players in the Prosthetic Heart Valve Market (18 Players)

*Top 13 Companies Analysed for This Study are - Edwards Lifesciences Corporation (U.S.), Medtronic PLC (Ireland), St. Jude Medical, Inc. (Abbott Laboratories Company) (U.S.), Boston Scientific Corporation (U.S.), Livanova PLC (U.K.), Symetis SA (Switzerland), Jenavalve Technology, Inc. (Germany), Cryolife, Inc. (U.S.), TTK Healthcare Limited (India), Colibri Heart Valve, LLC (U.S.), Lepu Medical Technology Co., Ltd. (China), and Braile Biomιdica (Brazil). Other Players in This Market Include Micro Interventional Devices, Inc. (U.S.), Autotissue Berlin GmbH (Germany), Comed B.V. (Netherlands), Meril Life Sciences Pvt. Ltd. (India), Labcor Laboratσrios Ltda. (Brazil), and Hlt Inc. (A Bracco Group Company) (U.S.)

9 Company Profiles (Page No. - 100)
(Overview, Products and Services, Financials, Strategy & Development)*
    9.1 Introduction
    9.2 Medtronic PLC
    9.3 Edwards Lifesciences Corporation
    9.4 Boston Scientific Corporation
    9.5 Livanova PLC
    9.6 St. Jude Medical, Inc. (An Abbott Laboratories Company)
    9.7 Symetis SA
    9.8 Jenavalve Technology, Inc.
    9.9 Cryolife, Inc.
    9.10 TTK Healthcare Limited (A TTK Group Company)
    9.11 Colibri Heart Valve, LLC
    9.12 Lepu Medical Technology Co., Ltd.
    9.13 Braile Biomιdica

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

10 Appendix (Page No. - 147)
     10.1 Discussion Guide
     10.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     10.3 Introducing RT: Real-Time Market Intelligence
     10.4 Available Customizations
     10.5 Related Reports
     10.6 Author Details


List of Tables (64 Tables)

Table 1 Global Prosthetic Heart Valve Market Snapshot
Table 2 Global Prosthetic Heart Valve Market Size, By Type of Valve, 2015–2022 (USD Million)
Table 3 Global Prosthetic Heart Valve Market Size, By Type of Valve, 2015–2022 (Units)
Table 4 Global Transcatheter Heart Valves Market Size, By Region, 2015–2022 (USD Million)
Table 5 Global Transcatheter Heart Valves Market Size, By Region, 2015–2022 (Units)
Table 6 North America: Transcatheter Heart Valves Market Size, By Country, 2015–2022 (USD Million)
Table 7 North America: Transcatheter Heart Valves Market Size, By Country, 2015–2022 (Units)
Table 8 Europe: Transcatheter Heart Valves Market Size, By Country, 2015–2022 (USD Million)
Table 9 Europe: Transcatheter Heart Valves Market Size, By Country, 2015–2022 (Units)
Table 10 Asia-Pacific Transcatheter Heart Valves Market Size, By Country, 2015–2022 (USD Million)
Table 11 Asia-Pacific: Transcatheter Heart Valves Market Size, By Country, 2015–2022 (Units)
Table 12 Global Tissue Heart Valves Market Size, By Region, 2015–2022 (USD Million)
Table 13 Global Tissue Heart Valves Market Size, By Region, 2015–2022 (Units)
Table 14 North America: Tissue Heart Valves Market Size, By Country, 2015–2022 (USD Million)
Table 15 North America: Tissue Heart Valves Market Size, By Country, 2015–2022 (Units)
Table 16 Europe: Tissue Heart Valves Market Size, By Country, 2015–2022 (USD Million)
Table 17 Europe: Tissue Heart Valves Market Size, By Country, 2015–2022 (Units)
Table 18 Asia-Pacific: Tissue Heart Valves Market Size, By Country, 2015–2022 (USD Million)
Table 19 Asia-Pacific: Tissue Heart Valves Market Size, By Country, 2015–2022 (Units)
Table 20 Global Mechanical Heart Valves Market Size, By Region, 2015–2022 (USD Million)
Table 21 Global Mechanical Heart Valves Market Size, By Region, 2015–2022 (Units)
Table 22 North America: Mechanical Heart Valves Market Size, By Country, 2015–2022 (USD Million)
Table 23 North America: Mechanical Heart Valves Market Size, By Country, 2015–2022 (Units)
Table 24 Europe: Mechanical Heart Valves Market Size, By Country, 2015–2022 (USD Million)
Table 25 Europe: Mechanical Heart Valves Market Size, By Country, 2015–2022 (Units)
Table 26 Asia-Pacific: Mechanical Heart Valves Market Size, By Country, 2015–2022 (USD Million)
Table 27 Asia-Pacific: Mechanical Heart Valves Market Size, By Country, 2015–2022 (Units)
Table 28 Global Prosthetic Heart Valves Market Size, By Region, 2015–2022 (USD Million)
Table 29 Global Prosthetic Heart Valves Market Size, By Region, 2015–2022 (Units)
Table 30 North America: Artificial Heart Valve Market Size, By Country, 2015–2022 (USD Million)
Table 31 North America: Artificial Heart Valve Market Size, By Country, 2015–2022 (Units)
Table 32 North America: Artificial Heart Valve Market Size, By Type, 2015–2022 (USD Million)
Table 33 North America: Artificial Heart Valve Market Size, By Type, 2015–2022 (Units)
Table 34 Medicare National Average Coverage for Heart Valve Replacement Procedures
Table 35 U.S.: Prosthetic Heart Valve Market Size, By Type, 2015–2022 (USD Million)
Table 36 U.S.: Prosthetic Heart Valve Market Size, By Type, 2015–2022 (Units)
Table 37 Canada: Prosthetic Heart Valve Market Size, By Type, 2015–2022 (USD Million)
Table 38 Canada: Prosthetic Heart Valve Market Size, By Type, 2015–2022 (Units)
Table 39 Europe: Artificial Heart Valve Market Size, By Country, 2015–2022 (USD Million)
Table 40 Europe: Artificial Heart Valve Market Size, By Country, 2015–2022 (Units)
Table 41 Europe: Artificial Heart Valve Market Size, By Type, 2015–2022 (USD Million)
Table 42 Europe: Artificial Heart Valve Market Size, By Type, 2015–2022 (Units)
Table 43 Germany: Prosthetic Heart Valve Market Size, By Type, 2015–2022 (USD Million)
Table 44 Germany: Prosthetic Heart Valve Market Size, By Type, 2015–2022 (Units)
Table 45 France: Prosthetic Heart Valve Market Size, By Type, 2015–2022 (USD Million)
Table 46 France: Prosthetic Heart Valve Market Size, By Type, 2015–2022 (Units)
Table 47 U.K.: Artificial Heart Valve Market Size, By Type, 2015–2022 (USD Million)
Table 48 U.K.: Artificial Heart Valve Market Size, By Type, 2015–2022 (Units)
Table 49 RoE: Artificial Heart Valve Market Size, By Type, 2015–2022 (USD Million)
Table 50 RoE: Artificial Heart Valve Market Size, By Type, 2015–2022 (Units)
Table 51 Asia-Pacific: Prosthetic Heart Valve Market Size, By Country, 2015–2022 (USD Million)
Table 52 Asia-Pacific: Prosthetic Heart Valve Market Size, By Country, 2015–2022 (Units)
Table 53 Asia-Pacific: Prosthetic Heart Valve Market Size, By Type, 2015–2022 (USD Million)
Table 54 Asia-Pacific: Prosthetic Heart Valve Market Size, By Type, 2015–2022 (Units)
Table 55 Japan: Artificial Heart Valve Market Size, By Type, 2015–2022 (USD Million)
Table 56 Japan: Artificial Heart Valve Market Size, By Type, 2015–2022 (Units)
Table 57 China: Artificial Heart Valve Market Size, By Type, 2015–2022 (USD Million)
Table 58 China: Artificial Heart Valve Market Size, By Type, 2015–2022 (Units)
Table 59 India: Prosthetic Heart Valve Market Size, By Type, 2015–2022 (USD Million)
Table 60 India: Prosthetic Heart Valve Market Size, By Type, 2015–2022 (Units)
Table 61 RoAPAC: Prosthetic Heart Valve Market Size, By Type, 2015–2022 (USD Million)
Table 62 RoAPAC: Prosthetic Heart Valve Market Size, By Type, 2015–2022 (Units)
Table 63 RoW: Artificial Heart Valve Market Size, By Type, 2015–2022 (USD Million)
Table 64 RoW: Artificial Heart Valve Market Size, By Type, 2015–2022 (Units)


List of Figures (35 Figures)

Figure 1 Global Prosthetic Heart Valves Market Segmentation
Figure 2 Global Prosthetic Heart Valves Market: Research Methodology Steps
Figure 3 Key Data From Secondary Sources
Figure 4 Primary Research - Current Sampling Frame
Figure 5 Break Down of Primary Interviews: By Company Type, Designation, and Region
Figure 6 Market Size Estimation Methodology: Global Market
Figure 7 Market Size Estimation Methodology: Bottom-Up Approach for the Transcatheter Heart Valves Market
Figure 8 Market Size Estimation Methodology: Bottom-Up Approach for the Tissue Heart Valves Market
Figure 9 Market Size Estimation Methodology: Bottom-Up Approach for the Mechanical Heart Valves Market
Figure 10 Market Size Estimation Methodology: Bottom-Up Approach for the Global Prosthetic Heart Valves Market
Figure 11 Market Size Estimation Methodology: Top-Down Approach
Figure 12 Data Triangulation Methodology
Figure 13 Transcatheter Heart Valves Segment to Register the Highest CAGR From 2017 to 2022
Figure 14 North America to Register the Highest CAGR in the Forecast Period
Figure 15 Evolution of Prosthetic Heart Valves
Figure 16 Rising Prevalence of Heart Valve Disease is One of the Major Factors Driving the Growth of the Prosthetic Heart Valves Market
Figure 17 Transcatheter Heart Valves to Register the Highest CAGR During the Forecast Period
Figure 18 North America to Register the Highest CAGR During the Forecast Period
Figure 19 Global Prosthetic Heart Valves Market: Drivers, Restraints, Opportunities, and Challenge
Figure 20 Global Prosthetic Heart Valves Market, By Type of Valve
Figure 21 Transcatheter Heart Valves Segment to Grow at the Highest CAGR During the Forecast Period
Figure 22 North America: Prosthetic Heart Valves Market Snapshot
Figure 23 Europe: Prosthetic Heart Valves Market Snapshot
Figure 24 Asia-Pacific: Prosthetic Heart Valves Market Snapshot
Figure 25 RoW: Prosthetic Heart Valves Market Snapshot
Figure 26 Vendor Dive Comparison Matrix: Prosthetic Heart Valves Market
Figure 27 Product Mix of Key Players in Market
Figure 28 Medtronic PLC: Company Snapshot (2015)
Figure 29 Edwards Lifesciences Corporation: Company Snapshot (2016)
Figure 30 Boston Scientific Corporation: Company Snapshot (2016)
Figure 31 Neovasc Inc.: Company Snapshot (2016)
Figure 32 Livanova PLC: Company Snapshot (2016)
Figure 33 St. Jude Medical, Inc. (An Abbott Laboratories Company): Company Snapshot (2015)
Figure 34 Cryolife, Inc.: Company Snapshot (2016)
Figure 35 TTK Healthcare Limited: Company Snapshot (2015)

The prosthetic heart valve market is projected to reach USD 8.86 Billion by 2022 from USD 4.84 Billion in 2017, at a CAGR of 12.9%. The key factors propelling the growth of this market include the rising geriatric population and the subsequent increase in the prevalence of HVD, regulatory approvals for new and advanced prosthetic heart valves, increasing government funding for heart valve research, rising awareness about HVD, and favorable reimbursement scenario for prosthetic heart valves.

In this report, the prosthetic heart valve market has been segmented based on the type of valve and region. On the basis of the type of valve, the market is segmented into transcatheter heart valves, tissue heart valves, and mechanical heart valves. The transcatheter heart valves segment is expected to command the largest share of the global market in 2017 and is expected to register the highest CAGR of 18.0% during the forecast period. The large share and high growth rate of this segment can be attributed to the rising prevalence of aortic stenosis, increasing pool of patients owing to approvals for extended valve indications, and technological advancements. The preference for transcatheter heart valves is expected to witness high growth in the future as they are implanted through a minimally invasive procedure while the other valve types require open-heart surgery.

Heart Valve/ Artificial Heart Valve Market

In 2017, North America is expected to dominate the prosthetic heart valve market, followed by Europe, Asia-Pacific, and the RoW. North America is also expected to register the highest CAGR during the forecast period. The large share and high growth in this regional segment can be attributed to factors such as the rapid growth in the aging population and prevalence of valvular heart diseases, favorable reimbursement scenario, and rising product approvals for heart valves are contributing to the growth of the North American prosthetic heart valve market.

A majority of the leading players in this market are focusing on marketing and promotional activities, product launches and approvals, acquisitions, agreements, collaborations, and expansions to enhance their market presence and strengthen their distribution networks, cater to the needs of a growing customer base, widen their product portfolios, and boost their production capabilities. Edwards Lifesciences Corporation (U.S.), Medtronic plc (Ireland), and St. Jude Medical, Inc. (an Abbott Laboratories Company) (U.S.) are identified as the top players in this market. These companies have a diversified product portfolio, wide geographic reach, and a strong focus on innovation and research.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Medical Devices Markets on KnowledgeStore
Request Demo